LiDCO Group Plc 24 April 2008 Press Release 24 April 2008 LiDCO Group Plc ("LiDCO" or the "Company") Appointment of Group Finance Director LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, today announces the appointment of Paul Leighton Clifford as Group Finance Director with effect from 23 April 2008. Dr Terry O'Brien, CEO of LiDCO, commented: "We are delighted to welcome Paul to the Company. He has excellent financial and commercial credentials that will play an increasingly valuable role as LiDCO's next period of growth takes us towards profitability and positive cashflow." Paul, aged 56, qualified as a chartered accountant with Touche Ross (now Deloittes) and has spent over 25 years in growth technology companies. He joins LiDCO from AIM quoted Civica plc, where he was Finance Director of its £80 million turnover operating subsidiary, Civica UK Limited, from 2006 until early 2008. Paul was Group Finance Director of London Stock Exchange quoted software group Comino Group plc from 1996 until it was acquired by Civica plc in early 2006. Comino floated on Aim in 1997 and moved to the Official list on 20 July 1999. In 1991, Paul co-founded and was a director of BCS Computing Limited ("BCS"), a start up company backed by venture capital funds to invest in vertical market software companies. BCS was re-organised into Comino Group in 1996. In addition to these roles, Paul has held other senior managerial and financial roles, primarily in the software and computing services sectors and has experience in mergers and acquisition, post- acquisition integration commercial contracts, company secretarial matters and risk management. In accordance with Schedule 2(g) of the AIM Rules, the following information in relation to the appointment of Paul Clifford to the Board of LiDCO Group Plc, is disclosed below: Current Directorships Directorships held in the past five years Paul Clifford has no other current Directorships Civica UK Limited Comino Group plc - ENDS - For more information please contact: LiDCO Group Plc Terry O'Brien - Chief Executive Tel: +44 (0)20 7749 1500 John Rowland - Company Secretary www.LiDCO.co.uk Panmure Gordon and Co Edward Farmer/ Katherine Roe +44 (0)20 7459 3600 www.panmure.com Media enquiries Abchurch Communications Heather Salmond / Stephanie Cuthbert 0207 398 7718 Stephanie.cuthbert@abchurch-group.com www.abchurch-group.com About LiDCO Group Plc LiDCO is a leading supplier of minimally invasive hemodynamic monitoring equipment and disposables. These are used primarily for the management of hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology significantly reduces the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please see www.lidco.com. The Company's manufacturing facility is in Hoxton, London and its current products are: * LiDCOplus and PulseCO monitors: these computer-based platforms are used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV% and SVV%) * LiDCO disposables: used in conjunction with the LiDCOplus Monitor for accurate measurement of cardiac output in a minimally invasive manner * LiDCOview: an easy-to-use graphical display of historical LiDCOplus hemodynamic data. Both clinical researchers and routine users can view beat-to-beat hemodynamic data collected with the LiDCOplus. LiDCOviewSE is the standard version of this tool and is available for free, allowing anyone to download and access data from the LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse, export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available for evaluation purposes prior to purchase * LiDCOlive: a software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus or LiDCOrapid monitors * LiDCOrapid : our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management at the point of care Distribution Network: The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors. This information is provided by RNS The company news service from the London Stock Exchange